Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02744118 · ClinicalTrials.gov registry record · NA

Helping Eliminate Marijuana Use Through Pediatric Practice

A NA study, sponsored by American Academy of Pediatrics.

Completed
Registry status
NA
Development phase
620
Enrollment target

NCT02744118: Completed NA study, sponsored by American Academy of Pediatrics.

NCT02744118 is a NA study that has completed, run by American Academy of Pediatrics. The registered enrollment target is 620 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02744118, a NA study, has completed, sponsored by American Academy of Pediatrics.

COMPLETED
Registry status
NA
Development phase
620 participants
Enrollment target

Study Summary

This study adapts the Public Health Service (PHS) 5As model for use with adolescent marijuana users and pilot the intervention to test feasibility and acceptability in pediatric primary care settings. The specific aims are as follows: Aim 1: Develop a marijuana screening and brief counseling intervention for adolescents based on the Public Health Service 5As model and previously developed adolescent smoking cessation intervention. Hypothesis 1: The 5As model can be adapted for use as a marijuana screening and counseling intervention for adolescents. Aim 2: Test the feasibility and acceptability of the 5As marijuana screening and brief counseling intervention in pediatric primary care practice. Hypothesis 2a: Pediatric clinicians will find the 5As intervention feasible and acceptable for addressing marijuana use in routine clinical visits with adolescents and their families; and Hypothesis 2b: Adolescents will find the 5As intervention delivered by their clinicians to be acceptable in the context of routine preventive services delivery.

Primary Outcome

Via a baseline survey and a phone interview 3-6 weeks later, using the Timeline Followback Method (TLFB), adolescents will be asked to report their current marijuana-use status, and will explore whether receiving the intervention affects motivation, intentions to quit and reduce use, or change in marijuana-use habits. Marijuana use will be defined as smoking or ingestion of any part of the marijuana plant; categories include: ever user, past month (current) user; past week and daily user. Addict

Interventions

  • OTHER 5A's Model
  • OTHER Healthy Internet Use Model

Trial Details

FieldValue
Enrollment Target 620 participants
Start Date 2016-04
Est. Completion 2020-03
Phase NA
American Academy of Pediatrics

3 total trials

What the finished NCT02744118 record still lists

NCT02744118 is an interventional study that assigns participants to a tested intervention. The registered 620 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).

The record links to 0 conditions, and to 2 interventions - of which 5A's Model is the first listed.

NCT02744118 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02744118 about?

NCT02744118 is a clinical study titled "Helping Eliminate Marijuana Use Through Pediatric Practice". This study adapts the Public Health Service (PHS) 5As model for use with adolescent marijuana users and pilot the intervention to test feasibility and acceptability in pediatric primary care settings. The specific aims are as follows: Aim 1: Develop a marijuana screening and brief counseling interv...

What is the current status of trial NCT02744118?

This trial is currently completed. It is a NA study. The enrollment target is 620 participants. The study started on 2016-04. Estimated completion is 2020-03.

What interventions are being tested in trial NCT02744118?

The interventions under investigation include: 5A's Model (OTHER), Healthy Internet Use Model (OTHER).

Who is sponsoring clinical trial NCT02744118?

This trial is sponsored by American Academy of Pediatrics, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02744118's enrollment target sits among peer trials

620 161st of 2000 higher than 1,840 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02282969 · 620 participants

    PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

  • NCT02838836 · 620 participants

    Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

  • NCT05538910 · 620 participants · NA

    Defining Neurobiological Links Between Substance Use and Mental Illness

  • NCT05822466 · 620 participants · NA

    Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02744118, the US trial registry maintained by the National Library of Medicine. NCT02744118 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.